Open Access. Powered by Scholars. Published by Universities.®

Medical Toxicology Commons

Open Access. Powered by Scholars. Published by Universities.®

Wright State University

Medical Pharmacology

Articles 1 - 3 of 3

Full-Text Articles in Medical Toxicology

Magnitude Based Inference, Sharlo Bayless, Trevor J. Bihl Apr 2021

Magnitude Based Inference, Sharlo Bayless, Trevor J. Bihl

Medical Student Research Symposium Abstracts and Posters

Though its use is widespread in research, null hypothesis significance testing is not without flaws. Out of a desire to provide a more practical approach to solving statistical problems in certain fields, Magnitude Based Inference (MBI) was created. MBI is a statistical method that was developed by Will G Hopkins and Alan M Batterham, two researchers in Sports and Exercise Science, in 2009.The main issues that they wanted to address with null hypothesis significance testing (NHST),were: 1) the need for a large sample size,2) the confusing language, and 3) the arbitrary selection of a p value of 0.05 in testing …


Uvb-Induced Microvesicle Particle Release In Human Skin In Vivo Is Diminished Following Oral Vitamin C And E Antioxidant Administration, Benjamin Schmeusser, Cameron Mcglone, Jeffrey B. Travers Apr 2021

Uvb-Induced Microvesicle Particle Release In Human Skin In Vivo Is Diminished Following Oral Vitamin C And E Antioxidant Administration, Benjamin Schmeusser, Cameron Mcglone, Jeffrey B. Travers

Medical Student Research Symposium Abstracts and Posters

An important question in photobiology asks how Ultraviolet B (UVB, 290 – 320 nm) radiation, which mostly absorbs in the outer epidermis of skin, can generate a systemic response such as immunosuppression. Previous in vitro and ex vivo studies demonstrate UVB-dependent release of bioactive molecule-containing microvesicle particles (MVPs) from keratinocytes. Furthermore, MVP release is diminished upon antioxidant administration. The purpose of this study is to examine UVB-induced MVP release and antioxidant response in vivo. In this IRB-approved study, 8 male participants with Fitzpatrick type I or II skin were treated with 1000 J/m2 UVB irradiation to a 5 by 5 …


Triamcinolone With Vitamin D Synergistic Efficacy In Psoriasis, Steven Repas, Jeffrey B. Travers Apr 2021

Triamcinolone With Vitamin D Synergistic Efficacy In Psoriasis, Steven Repas, Jeffrey B. Travers

Medical Student Research Symposium Abstracts and Posters

Psoriasis is one of the most common skin conditions in the United States affecting more than 8 million people. High amounts of vitamin D has been shown to be effective in treatment of psoriasis. It also has a well-documented safety profile at the doses and duration that will be used during this study. Triamcinolone and other topical corticosteroids are considered a first line treatment for mild to moderate psoriasis with a well-documented safety profile. Individually both of these medications have shown effectiveness in the management and treatment of mild to moderate psoriasis. This study is designed to test whether a …